Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment Femtech Insider
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment femtechinsider.com
Analysis: Marijuana Access Associated With “Striking” Decline in Daily Opioid Use by IV Drug Consumers NORML
Endometriosis affects 10% of women of childbearing age and 25-50% of infertile women worldwide. Although most patients with endometriosis are completely asymptomatic, there is still a significant proportion of patients, …
Relief of Chronic Pain Act Part of Trump's War on Opioids Newsmax
Patients with endometriosis undergoing surgery are at risk of moderate-to-severe postoperative pain. Clonidine, an alpha-2 agonist with analgesic properties, may improve multimodal pain management in these patients.
Minimally invasive endometriosis surgery can be done laparoscopically or with robotic assistance. The choice of modality of this procedure could impact postprocedure pain levels and the need for opioids to …
Chronic pain is a widespread condition affecting millions globally, placing significant strain on healthcare systems, as evidenced by the current opioid crisis. Despite advances in pain management, conventional treatments often …
To examine real-world treatment patterns for endometriosis and their alignment with clinical best-practice recommendations.